Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate

Abstract Objectives. The purpose of this study was to explore drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors (TNFi) in clinical practice in patients with rheumatoid arthritis (RA) on low-dose methotrexate (MTX) or without MTX. Methods. A total of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Modern rheumatology 2015-03, Vol.25 (2), p.251-256
Hauptverfasser:	Kobayakawa, Tomonori, Kojima, Toshihisa, Takahashi, Nobunori, Hayashi, Masatoshi, Yabe, Yuichiro, Kaneko, Atsushi, Shioura, Tomone, Saito, Kiwamu, Hirano, Yuji, Kanayama, Yasuhide, Miyake, Hiroyuki, Asai, Nobuyuki, Funahashi, Koji, Hirabara, Shinya, Hanabayashi, Masahiro, Asai, Shuji, Ishiguro, Naoki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Biological Products - therapeutic use Cancer Drug Substitution Drug Therapy, Combination Female Humans Japan Male Medical treatment Methotrexate Methotrexate - therapeutic use Middle Aged Prescription drugs Rheumatoid arthritis Second-line drug Switching TNF inhibitor Tocilizumab Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!